Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenoptin Extension in PKU
NCT00225615Phase 3Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Nov 2005
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of sapropterin in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Nov 2005; status: completed.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT00225615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225615.